Dr. Copelan discusses the use of chimeric antigen receptor (CAR) T-cell therapy in non-Hodgkin lymphoma patients and how these therapies might improve upon the current standard of care.
Edward A. Copelan, MD
Advertisement
Articles by Edward A. Copelan, MD
Advertisement
Latest Updated Articles
CAR T-Cell Therapy in Non-Hodgkin Lymphoma PatientsPublished: February 15th 2019 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
Around the Helix: Cell and Gene Therapy Company Updates – October 29, 2025
2
Intellia Puts Phase 3 Trials for Transthyretin Amyloidosis Gene Editing Therapy Nex-Z on Hold Following Grade 4 Liver AE
3
Guess the Therapy Answer October 29, 2025
4
Quarter Century Update: What Lessons Should Guide the Next Generation of Developers and Regulators?
5
